Testimonials
Collated independently by Legal 500 research team.
‘The team has redefined high-end legal services through its investment-financing and dispute resolution dual-track integration model, embedding deep expertise in private fund clause design into litigation strategies.'
- 'With precision-focused industry capabilities in biopharma, AI, and semiconductors, the team leverages genomic-level equity structuring and pre-emptive data compliance screening to deliver solutions perfectly aligned with commercial realities.'
'Chengchen Gan has redefined high-end legal services through a "Partnership-Style Service" philosophy, from foundational equity structuring during the startup phase to proactive archival of closing documents and regulatory compliance filings post-financing. His systematic, end-to-end collaboration consistently elevated the entire process.'
'Particularly remarkable was his preemptive response protocol, demonstrated during critical scenarios such as emergency revisions and real-time synchronisation of cross-border regulatory communications, which ensured our strategic security throughout complex capital negotiations.'
'Chengchen Gan's unique ability to transform legal uncertainty into commercial predictability distinguishes him as a practitioner — a cornerstone advantage that sets him apart in the legal profession.’
Key clients
- Jiangsu Hengrui Pharmaceuticals Co., Ltd.
- Genor Biopharma Holdings Limited、
- Edding Group Company Limited
- Beijing Century Hong Shui Hospital Management Ltd.
- Alphamab Oncology
- Zai Lab Limited
- Giant Biogene Holding Co., Ltd.
- Ascentage Pharma Group International
- Concord Healthcare Group Co., Ltd.
- Thankcome Biological Science and Technology (SuZhou) Co., Ltd
Work highlights
Practice head
Xinyang Zhang; Xiaoman Zhang; Bo Wang; Jianhai Luan; Meng Zhang; Wei Sun; Amin Li; Wei Zhang; Min Yang; Qiang Cui
Other key lawyers
Chenchen Gan
